Toni-maree Rogers

St Andrews Place
East Melbourne, VIC 3002, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Editorial Expression of Concern: Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.

Editorial Expression of Concern: Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.

Journal: Nature medicine
Published: November 20, 2025

Identification errors in medical research: Privacy at all costs?

Identification errors in medical research: Privacy at all costs?

Journal: Contemporary clinical trials
Published: January 12, 2023

Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients.

Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients.

Journal: Pathology
Published: April 15, 2017

Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer.

Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer.

Journal: Scientific reports
Published: October 03, 2016

In Response.

In Response.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 23, 2015

Comparison of methods in the detection of ALK and ROS1 rearrangements in lung cancer.

Comparison of methods in the detection of ALK and ROS1 rearrangements in lung cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 20, 2015

Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases.

Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases.

Journal: Journal of clinical pathology
Published: March 05, 2015

Molecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyond.

Molecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyond.

Journal: Translational lung cancer research
Published: December 09, 2014

Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.

Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.

Journal: Nature medicine
Published: January 27, 2014

Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization.

Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 21, 2013

The molecular characterisation of unusual subcutaneous spindle cell lesion of breast.

The molecular characterisation of unusual subcutaneous spindle cell lesion of breast.

Journal: Journal of clinical pathology
Published: April 24, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026